Drug and Medical Device Lawsuits
The law firm of Aylstock, Witkin, Kreis & Overholtz is constantly monitoring reports of
safety problems in the fields of prescription drugs and medical devices. The lawyers at our firm
work closely with attorneys around the nation to pursue recoveries for our clients.
Often, attorneys from our firm are called upon to lead
Plaintiff Steerring Committees (PSCs) or other group efforts
in federal and state courts around the country
to move mass tort litigations forward on behalf of plaintiffs,
against global manufacturers.
We have established a reputation as leaders in this mass torts landscape,
accepting thousands of cases that
are referred to our firm from firms across the country on a regular basis.
Pelvic Mesh Problems: multiple FDA warnings
A doctor explains the problems with trans-vaginal mesh products.
(This video, by University of Utah Health Care, does not address the crucial, further subject of manufacturers' failure to properly
disclose known dangers before the FDA took action. However, it is a good explanation of the products.)
Defective Drugs & Medical Devices
Some of the drugs and devices we are watching closely or actively litigating include:
- POP/SUI mesh implants: problems associated with
trans-vaginal mesh (TVM) implants or
pelvic/bladder support systems;
- Women suffering from pelvic organ prolapse (POP)
and/or stress urinary incontinence (SUI) who
sought help from a trans-vaginal mesh implant or pelvic/
bladder support system may have been victims of
a defective medical device. After the shocking results
of a clinical study, victims are filing suit against the
manufacturers of the defective medical devices. Some
of the problems reported include: pain (localized radiating
into lower back or extremeties, and/or during
urination/ intercourse), infection, migration, erosion
and the need for corrective surgeries. These problems
can develop shortly after implantation, but may also
take years to develop.
- Yaz or Yasmin: blood clot risks associated with Yas/Yasmin birth control products
- SSRI anti-depressants: birth defects associated with:
- Bisphosphonates: femur fractures and/or osteonecrosis of the jaw (ONJ) associated with Fosamax, Actonel, Boniva, Aredia, Reclast and Zometa.
- IVC filters: blood clot risk associated with "inferior vena cava filters."
- joint replacements: failure of artificial joint systems, including:
- Actos: bladder cancer risk associated with Actos diabetes medication
- Pradaxa anticoagulant medications: uncontrollable bleeding risks associated with Pradaxa (dabigtran) administered to patients with atrial fibrillation
- Medtronic InFUSE Bone Graft: problems associated with inproper use of InFUSE (i.e. used with incorrect components or used on part of spine the product
was not approved for)
- Granuflo: heart attack or stroke associated with Granuflo or NaturaLyte used in dialysis
For details about any of the above topics, see the law firm's newsletter, avaialable online (7.54 MB download). The newsletter explains why
each of these products posed unnecessary or undisclosed dangers to patients. Our law firm is interested in
hearing from anyone who has suffered from these problems.